日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined Immediate-Release and Extended-Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation.

丙戊酸钠的速释和缓释联合制剂可提供稳定的血浆浓度,从而抑制组蛋白去乙酰化

Ahuja Nikhil, Kääriäinen Susanna, Lovró Zsófia, Lundblad Mia, Drott Kristina, Lilienberg Elsa, Engström Marica T, Saukkonen Karla, Scheinin Mika

First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis

首次人体试验,1期随机剂量递增试验,使用重组抗IL-20单克隆抗体治疗银屑病患者

Gottlieb, Alice B; Krueger, James G; Sandberg Lundblad, Mia; Göthberg, Marie; Skolnick, Brett E